191 related articles for article (PubMed ID: 9166292)
61. Possible involvement of TGF beta 1 in the distinct tumorigenic properties of two rat colon carcinoma clones.
Grégoire M; Garrigue L; Blottière HM; Denis MG; Meflah K
Invasion Metastasis; 1992; 12(3-4):185-96. PubMed ID: 1338201
[TBL] [Abstract][Full Text] [Related]
62. Expression of transforming growth factor alpha in normal human adult kidney and enhanced expression of transforming growth factors alpha and beta 1 in renal cell carcinoma.
Gomella LG; Sargent ER; Wade TP; Anglard P; Linehan WM; Kasid A
Cancer Res; 1989 Dec; 49(24 Pt 1):6972-5. PubMed ID: 2582439
[TBL] [Abstract][Full Text] [Related]
63. Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression.
Hsu S; Huang F; Hafez M; Winawer S; Friedman E
Cell Growth Differ; 1994 Mar; 5(3):267-75. PubMed ID: 8018559
[TBL] [Abstract][Full Text] [Related]
64. Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides.
Gnarra JR; Dressler GR
Cancer Res; 1995 Sep; 55(18):4092-8. PubMed ID: 7664285
[TBL] [Abstract][Full Text] [Related]
65. Transforming growth factor beta 1 induces apoptotic cell death in cultured human gastric carcinoma cells.
Yanagihara K; Tsumuraya M
Cancer Res; 1992 Jul; 52(14):4042-5. PubMed ID: 1319836
[TBL] [Abstract][Full Text] [Related]
66. Transforming growth factor beta 1 is significantly elevated in plasma of patients suffering from renal cell carcinoma.
Junker U; Knoefel B; Nuske K; Rebstock K; Steiner T; Wunderlich H; Junker K; Reinhold D
Cytokine; 1996 Oct; 8(10):794-8. PubMed ID: 8980881
[TBL] [Abstract][Full Text] [Related]
67. Restoration of expression of transforming growth factor-beta type II receptor in murine renal cell carcinoma (renca) cells by 5-Aza-2'-deoxycytidine.
Zhang Q; Rubenstein JN; Liu VC; Park I; Jang T; Lee C
Life Sci; 2005 Jan; 76(10):1159-66. PubMed ID: 15620579
[TBL] [Abstract][Full Text] [Related]
68. Characterization of interleukin-4 receptors expressed on human renal cell carcinoma cells.
Obiri NI; Puri RK
Oncol Res; 1994; 6(9):419-27. PubMed ID: 7703528
[TBL] [Abstract][Full Text] [Related]
69. Expression of transforming growth factor beta 1 by human endometrial carcinoma cell lines: inverse correlation with effects on growth rate and morphology.
Boyd JA; Kaufman DG
Cancer Res; 1990 Jun; 50(11):3394-9. PubMed ID: 2334934
[TBL] [Abstract][Full Text] [Related]
70. Reduction of transforming growth factor-beta type II receptor is caused by the enhanced ubiquitin-dependent degradation in human renal cell carcinoma.
Fukasawa H; Yamamoto T; Fujigaki Y; Misaki T; Ohashi N; Takayama T; Suzuki S; Mugiya S; Oda T; Uchida C; Kitagawa K; Hattori T; Hayashi H; Ozono S; Kitagawa M; Hishida A
Int J Cancer; 2010 Oct; 127(7):1517-25. PubMed ID: 20073064
[TBL] [Abstract][Full Text] [Related]
71. Effects of transforming growth factor beta on megakaryocytic cell fusion and endomitosis.
Cowley SA; Groopman JE; Avraham H
Int J Cell Cloning; 1992 Jul; 10(4):223-31. PubMed ID: 1645030
[TBL] [Abstract][Full Text] [Related]
72. Transforming growth factor beta and fibroblast growth factor as promoters of tumor progression to malignancy.
Wright JA; Turley EA; Greenberg AH
Crit Rev Oncog; 1993; 4(5):473-92. PubMed ID: 8241321
[TBL] [Abstract][Full Text] [Related]
73. Altered expression of TGF-beta receptors in hepatocellular carcinoma--effects of a constitutively active TGF-beta type I receptor mutant.
Musch A; Rabe C; Paik MD; Berna MJ; Schmitz V; Hoffmann P; Nischalke HD; Sauerbruch T; Caselmann WH
Digestion; 2005; 71(2):78-91. PubMed ID: 15775675
[TBL] [Abstract][Full Text] [Related]
74. Differential transfection efficiency rates of the GM-CSF gene into human renal cell carcinoma lines by lipofection.
Hernández A; Zöller K; Enczmann J; Ebert T; Schmitz-Draeger B; Ackermann R; Wernet P
Cancer Gene Ther; 1997; 4(1):59-65. PubMed ID: 9012452
[TBL] [Abstract][Full Text] [Related]
75. Clonal heterogeneity of the sensitivity of human colon carcinoma cell lines to TGE beta isoforms.
Zhou GH; Sechrist GL; Brattain MG; Mulder KM
J Cell Physiol; 1995 Dec; 165(3):512-20. PubMed ID: 7593230
[TBL] [Abstract][Full Text] [Related]
76. Transforming growth factor beta regulates differentiation and proliferation of human neuroblastoma.
Scarpa S; Coppa A; Ragano-Caracciolo M; Mincione G; Giuffrida A; Modesti A; Colletta G
Exp Cell Res; 1996 Nov; 229(1):147-54. PubMed ID: 8940258
[TBL] [Abstract][Full Text] [Related]
77. Loss of transforming growth factor-beta type II receptor gene expression in primary human esophageal cancer.
Garrigue-Antar L; Souza RF; Vellucci VF; Meltzer SJ; Reiss M
Lab Invest; 1996 Aug; 75(2):263-72. PubMed ID: 8765326
[TBL] [Abstract][Full Text] [Related]
78. Role of receptor complexes in resistance or sensitivity to growth inhibition by TGF beta in intestinal epithelial cell clones.
Mulder KM; Segarini PR; Morris SL; Ziman JM; Choi HG
J Cell Physiol; 1993 Jan; 154(1):162-74. PubMed ID: 8380421
[TBL] [Abstract][Full Text] [Related]
79. Responsiveness of three newly established human colorectal cancer cell lines to transforming growth factors beta 1 and beta 2.
Suardet L; Gaide AC; Calmès JM; Sordat B; Givel JC; Eliason JF; Odartchenko N
Cancer Res; 1992 Jul; 52(13):3705-12. PubMed ID: 1617643
[TBL] [Abstract][Full Text] [Related]
80. Expression of N-CAM by human renal cell carcinomas correlates with growth rate and adhesive properties.
Zocchi MR; Ferrero E; Toninelli E; Castellani P; Poggi A; Rugarli C
Exp Cell Res; 1994 Oct; 214(2):499-509. PubMed ID: 7523154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
